Molecular Partners Ag (MOLN) Cash from Operations (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Cash from Operations for 7 consecutive years, with -$31.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations rose 13.11% year-over-year to -$31.7 million in Q2 2026; TTM through Jun 2026 was -$58.0 million, a 13.18% increase from a year earlier, with the FY2025 full-year figure at -$61.8 million, up 8.2% from the prior year.
• Cash from Operations was -$31.7 million for Q2 2026 at Molecular Partners Ag, down from -$18188.4 in the prior quarter.
• Over five years, Cash from Operations peaked at $156.6 million in Q2 2022 and troughed at -$156.2 million in Q3 2022.
• A 5-year average of -$5.7 million and a median of -$14.9 million in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations soared 635.85% in 2022 and sank 10199.44% in 2023, its largest moves.
• Over 5 years, Cash from Operations stood at $122.9 million in 2022, then plunged by 114.66% to -$18.0 million in 2023, then grew by 16.43% to -$15.1 million in 2024, then advanced by 7.37% to -$14.0 million in 2025, then plunged by 126.91% to -$31.7 million in 2026.
• The last three Cash from Operations figures came in at -$31.7 million (Q2 2026), -$18188.4 (Q1 2026), and -$14.0 million (Q4 2025), per Business Quant data.